AIM Suspension - Beximco Pharmaceuticals Limited
November 11 2024 - 1:30AM
RNS Regulatory News
RNS Number : 6851L
AIM
11 November 2024
NOTICE
11/11/2024 7:30am
TEMPORARY SUSPENSION OF TRADING ON AIM
BEXIMCO PHARMACEUTICALS
LIMITED
At the request of the Company,
trading on AIM for the under-mentioned securities was temporarily
suspended from 11/11/2024 7:30am, pending an
announcement.
GLOBAL DEPOSITARY RECEIPTS (EACH
REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID
(B0DM5S5) (US0885792061)
If you have any queries relating to
the above, please contact the Company's nominated adviser
on +44 (0) 20 3368 3551.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
EXCZZMMMNMGGDZG
Beximco Pharma (LSE:BXP)
Historical Stock Chart
From Oct 2024 to Nov 2024
Beximco Pharma (LSE:BXP)
Historical Stock Chart
From Nov 2023 to Nov 2024